Short Squeeze

We have lowered our subscription by 50%. Now just $9.99/Month. Adding more value to our customers.

Rodgers walking into meeting with Mike McCarthy

$ASTS keeps running

$ASTS has been a huge runner our AI caught. Still running from entry on May 16!

$NVAX has been the best squeeze last month, its not $GME. Follow the AI not sentiment

Our AI signaled $GME on 5/3 and its up decent from there.

$ACB has been on a trend recently

$SMR has been squeezing well

$ARQT climbed even further

$ARQT in 200% club. Slowly squeezing since December.

$IMPP in the 100% club

Recent big runners $RUN $MARA $RXRX $TGTX

$MLGO was signaled on 11/21, but it ended up selling off, but it was still on the AI's list. Today it paid off with the squeeze

Basic Buy and hold squeeze strategy has an average realistic return of 6% per trade. With proper risk sizing, This will destroy Stock market returns on an annual basis. $SPY $QQQ $AAPL $TSLA $NVDA $VIX

Some latest big runners $OMER $MDGL $TGTX

AI has been on a roll lately with strong market $SRG $HARP $BTAI $PDSB $DFH

@JosPorsche The AI only focuses on stocks with highest potential for mega squeeze, not small squeezes. A stock that is beat down has low probability, because the shorts are sitting on a profit and no need to cover except close out position.

@ShortSqueezeApp U are wrong. But time will tell. Q3 wasn't that bad as bears where telling & Q-10 form was normal. After that the stock went from -10% @ opening to +6% becuz bag holders where squeezing the shorters on avg down and Shoeters where dumping to reduce their potential loss.

@ShortSqueezeApp Your AI mod missed $FSR #Shortsqueeze yesterday completely?

@VerveTxSqueeze Price moves on supply and supply demand in the short term, it’s impossible to reason why the it moves.

@ShortSqueezeApp I understand clinical trial results are binary, but it seems to me the results had nothing to do with the crash. Which means it was not binary at all. It was an orchestrated premarket crash. Thoughts?

We have lowered our subscription by 50%. Now just $9.99/Month. Adding more value to our customers.

Great pull back squeeze on $IBRX. Market has been strong recently so AI stats have been higher

@VerveTxSqueeze It was signaled on 11/03 and had a nice 20% return. Before a clinical trial release crashed it. TBH I don’t have much confidence on it, unless it can get over $20 price. As mentioned in the App clinical trial released are something to watch out for as they are binary events.

@ShortSqueezeApp How does your AI think $VERV looks for a short squeeze. I am thinking the leg work has already been done, we just need to push it over the edge.